RAPT Therapeutics (RAPT) Total Liabilities: 2020-2024
Historic Total Liabilities for Therapeutics (RAPT) over the last 5 years, with Sep 2024 value amounting to $13.0 million.
- Therapeutics' Total Liabilities fell 51.86% to $13.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $13.0 million, marking a year-over-year decrease of 51.86%. This contributed to the annual value of $26.3 million for FY2023, which is 24.95% up from last year.
- As of Q3 2024, Therapeutics' Total Liabilities stood at $13.0 million, which was down 27.85% from $18.0 million recorded in Q2 2024.
- Therapeutics' Total Liabilities' 5-year high stood at $27.9 million during Q1 2023, with a 5-year trough of $12.3 million in Q4 2021.
- Its 3-year average for Total Liabilities is $21.7 million, with a median of $21.0 million in 2022.
- Per our database at Business Quant, Therapeutics' Total Liabilities soared by 71.70% in 2022 and then slumped by 51.86% in 2024.
- Therapeutics' Total Liabilities (Quarterly) stood at $14.8 million in 2020, then decreased by 17.13% to $12.3 million in 2021, then skyrocketed by 71.70% to $21.0 million in 2022, then increased by 24.95% to $26.3 million in 2023, then slumped by 51.86% to $13.0 million in 2024.
- Its Total Liabilities stands at $13.0 million for Q3 2024, versus $18.0 million for Q2 2024 and $25.0 million for Q1 2024.